Related Experiment Video
Updated: Jan 22, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
13.3K
Perspectives on Registry-Based Research in Heart Failure: Current Status and Future Directions
Christian Basile1,2, Felix Lindberg1, Gianluigi Savarese3
1Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Korean Circulation Journal
|January 21, 2026
Summary
Heart failure (HF) registries track millions of patients, offering real-world insights beyond clinical trials. These registries are vital for improving patient care and advancing HF research through innovative methods.
Area of Science:
- Cardiology
- Clinical Research
- Health Informatics
Background:
- Heart failure (HF) registries bridge the gap between clinical trials and practice.
- Millions of patients have been enrolled across diverse HF spectrums in global registries.
- Early initiatives like ADHERE and EuroHeart Failure Survey paved the way for larger programs.
Purpose of the Study:
- To provide a global overview of the evolution of HF registries.
- To analyze the scientific yield and impact of HF registries.
- To discuss the future potential and advancements in HF registry research.
Main Methods:
- Review of historical and current heart failure registries worldwide.
- Analysis of registry-based studies on HF epidemiology, phenotypes, and treatment.
- Exploration of registry-based randomized controlled trials and methodological advances.
Main Results:
- Registries offer insights into HF epidemiology, risk factors, and real-world treatment.
- They address questions not feasible in randomized trials, like therapy withdrawal.
- Registry-based trials provide pragmatic intervention testing at lower costs.
Conclusions:
- HF registries are essential for a learning healthcare system.
- Methodological advances enhance registry validity and relevance.
- Future potential lies in leveraging electronic records and causal inference techniques.
Related Concept Videos
01:29Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
01:22Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
01:22Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
01:30Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227